Search results for "PHARMACOLOGY & PHARMACY"

showing 10 items of 329 documents

New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology

2019

The American Society for Pharmacology and Experimental Therapeutics has revised the Instructions to Authors for Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, and Molecular Pharmacology These revisions relate to data analysis (including statistical analysis) and reporting but do not tell investigators how to design and perform their experiments. Their overall focus is on greater granularity in the description of what has been done and found. Key recommendations include the need to differentiate between preplanned, hypothesis-testing, and exploratory experiments or studies; explanations of whether key elements of study design, such as sample size and …

Data AnalysisSocieties Scientific0301 basic medicineResearch designBiomedical ResearchComputer scienceBar chartDrug Evaluation PreclinicalMEDLINEPharmaceutical ScienceGuidelines as TopicBiostatistics030226 pharmacology & pharmacylaw.invention03 medical and health sciences0302 clinical medicinelawHumansStatistical hypothesis testingPeer Review ResearchPublishingPharmacologyInformation retrievalUnited StatesConfidence interval3. Good health030104 developmental biologyData pointResearch DesignSample size determinationData Interpretation Statistical030220 oncology & carcinogenesisScatter plotPractice Guidelines as TopicOutlierMolecular MedicinePeriodicals as TopicEditorial Policies030217 neurology & neurosurgeryDrug Metabolism and Disposition
researchProduct

Comparative efficacy of aloe vera mouthwash and chlorhexidine on periodontal health: A randomized controlled trial

2016

Background: With introduction of many herbal medicines, dentistry has recently evidenced shift of approach for treating many inflammatory oral diseases by using such modalities. Aloe vera is one such product exhibiting multiple benefits and has gained considerable importance in clinical research recently. Aims: To compare the efficacy of Aloevera and Chlorhexidine mouthwash on Periodontal Health. Material and Methods: Thirty days randomized controlled trial was conducted among 390 dental students. The students were randomized into two intervention groups namely Aloe Vera (AV) chlorhexidine group (CHX) and one control (placebo) group. Plaque index and gingival index was recorded for each par…

DentistryOdontologíaDental plaquePlacebo030226 pharmacology & pharmacyAloe veralaw.invention03 medical and health sciencesGingivitis0302 clinical medicineRandomized controlled triallawPost-hoc analysismedicineGeneral Dentistrybiologybusiness.industryResearchChlorhexidineSignificant difference030206 dentistrymedicine.diseasebiology.organism_classificationCiencias de la saludCommunity and Preventive DentistryUNESCO::CIENCIAS MÃ DICAS:CIENCIAS MÃ DICAS [UNESCO]medicine.symptombusinessmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Simultaneous quantification of 18 different phytocannabinoids in serum using a highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS…

2021

Abstract The potential therapeutic effects of various phytocannabinoids and the availability of multiple cannabis-based medicines make it desirable to have an analytical method that simultaneously quantifies a wide range of cannabinoids in blood, beyond delta-9-tetrahydrocannabinol and its metabolites. A liquid chromatography tandem mass spectrometry (LC-MS/MS) method for quantification of 18 phytocannabinoids and cannabinoid metabolites in serum was developed and validated. The method enables simultaneous detection of delta-9-tetrahydrocannabinol, cannabidiol, cannabinol, cannabigerol, cannabichromene, cannabicyclol, tetrahydrocannabivarin and cannabidivarin and their acidic precursors tet…

Detection limitChromatographyCannabigerol010401 analytical chemistryClinical BiochemistryCell BiologyGeneral MedicineTetrahydrocannabivarin030226 pharmacology & pharmacy01 natural sciencesBiochemistryCannabicyclol0104 chemical sciencesAnalytical Chemistry03 medical and health scienceschemistry.chemical_compoundCannabichromene0302 clinical medicinechemistryLiquid chromatography–mass spectrometrymedicineCannabinolSolid phase extractionmedicine.drugJournal of chromatography. B, Analytical technologies in the biomedical and life sciences
researchProduct

Predictability of drug encapsulation and release from propylene carbonate/PLGA microparticles.

2020

Abstract Key parameters for microparticle-based parenteral depot formulation development are entrapment efficiency and sustained drug release, which both depend on the intermolecular affinity of the components. Here, partial solubility parameters were evaluated as descriptors for 21 drug substances and 3 polymers in propylene carbonate (PC). Out of these 21 drug substances, eight BCS class II substances (celecoxib, clotrimazole, erythromycin, ibuprofen, indomethacin, itraconazole, lopinavir and ritonavir) were encapsulated using PLGA (Poly(DL-lactide-co-glycolide)) as polymer matrix and PC as a polar aprotic solvent in order to assign microparticle properties to potential affinity-related i…

Drug CompoundingPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compoundPropane0302 clinical medicinePolylactic Acid-Polyglycolic Acid CopolymermedicineLactic AcidMicroparticleSolubilityParticle SizeChemistry021001 nanoscience & nanotechnologyIbuprofenMicrospheresSolventHildebrand solubility parameterPLGAChemical engineeringPharmaceutical PreparationsSolubilityPropylene carbonate0210 nano-technologyGlass transitionPolyglycolic Acidmedicine.drugInternational journal of pharmaceutics
researchProduct

A survey on IVIVC/IVIVR development in the pharmaceutical industry – Past experience and current perspectives

2017

The present work aimed to describe the current status of IVIVC/IVIVR development in the pharmaceutical industry, focusing on the use and perception of specific approaches as well as successful and failed case studies. Two questionnaires have been distributed to 13 EFPIA partners of the Oral Biopharmaceutics Tools Initiative and to the Pharmacokinetics Working Party of the European Medicines Agency in order to capture the perspectives and experiences of industry scientists and agency members, respectively. Responses from ten companies and three European Agencies were received between May 21st 2014 and January 19th 2016. The majority of the companies acknowledged the importance of IVIVC/IVIVR…

Drug IndustryOperations researchPharmaceutical Science02 engineering and technologyModels Biological030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineIVIVCSurveys and QuestionnairesDrug DiscoveryAgency (sociology)AnimalsHumansRelevance (law)MedicinePharmacokineticsMarketingPharmaceutical industryRate of returnFlexibility (engineering)business.industry021001 nanoscience & nanotechnologyDrug developmentPositive attitude0210 nano-technologybusinessEuropean Journal of Pharmaceutical Sciences
researchProduct

Stability of tacrolimus ophthalmic solution

2017

Purpose The stability of 0.3-mg/mL tacrolimus ophthalmic solution at different storage temperatures was studied. Methods A sterile ophthalmic solution of 0.3 mg/mL tacrolimus was prepared in triplicate under aseptic conditions by diluting tacrolimus in eye drops. Three aliquots of this solution were transferred into polypropylene bottles and stored at 25, 2–8, or −15 to −25 °C. Samples were collected immediately after preparation and at selected time points and assayed in triplicate using high-performance liquid chromatography (HPLC). Samples were also visually examined for macroscopic changes. The 0.3-mg/mL tacrolimus solution was also exposed to acidic treatment and heat to force its degr…

Drug Storagemedicine.medical_treatmentAdministration Ophthalmicchemical and pharmacologic phenomena030226 pharmacology & pharmacyHigh-performance liquid chromatographyTacrolimus03 medical and health sciences0302 clinical medicineDrug StabilitymedicineHumansChromatography High Pressure LiquidPharmacologyChromatographyChemistryHealth PolicyTemperatureEye dropTacrolimusPharmaceutical Solutionssurgical procedures operativeOphthalmic solutionsAnesthesia030221 ophthalmology & optometryAseptic processingOphthalmic SolutionsImmunosuppressive AgentsAmerican Journal of Health-System Pharmacy
researchProduct

Core-Shell Arginine-Containing Chitosan Microparticles for Enhanced Transcorneal Permeation of Drugs

2019

Chitosan oligosaccharide (C) was functionalized with L-arginine (A) and short hydrocarbon chains (C-8) to design an amphiphilic copolymer, henceforth CAC(8), leading to microparticles (MPs) consisting of an arginine-decorated hydrophilic shell and inner hydrophobic domains allowing the encapsulation of high amount hydrophobic drugs such as sorafenib tosylate (>10% w/w). L-arginine side chains were selected in order to impart the final MPs enhanced transcorneal penetration properties, thus overcoming the typical biological barriers which hamper the absorption of drugs upon topical ocular administration. The mucoadhesive properties and drug release profile of the CAC(8) MPs (CAC(8)-MPs) were …

Drug3003congenital hereditary and neonatal diseases and abnormalitiesArginineSwinemedia_common.quotation_subjectamphiphilic copolymerPharmaceutical ScienceL-arginineAdministration Ophthalmic02 engineering and technologyArginine030226 pharmacology & pharmacyCorneaChitosan03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMucoadhesionSide chainAnimalsskin and connective tissue diseasesProtein Kinase Inhibitorsmedia_commonMucin-3microparticlesDrug CarriersMucinnutritional and metabolic diseasesSorafenibPermeation021001 nanoscience & nanotechnologyCombinatorial chemistryBioavailabilityDrug LiberationmicroparticlechemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoocular administrationchitosan0210 nano-technologymucoadhesion
researchProduct

3D-Printed Solid Dispersion Drug Products.

2019

With the well-known advantages of additive manufacturing methods such as three-dimensional (3D) printing in drug delivery, it is disappointing that only one product has been successful in achieving regulatory approval in the past few years. Further research and development is required in this area to introduce more 3D printed products into the market. Our study investigates the potential of fixed dose combination solid dispersion drug products generated via 3D printing. Two model drugs&mdash

Drug3d printedMaterials sciencemedia_common.quotation_subjecteducationPharmaceutical Science3D printing02 engineering and technology030226 pharmacology & pharmacyPolyvinyl alcoholArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineamorphous solid dispersionfixed dose combinationmedia_commonbusiness.industry3D printing021001 nanoscience & nanotechnologySolventpoor solubilitychemistryChemical engineeringDrug deliveryManufacturing methods0210 nano-technologybusinessDispersion (chemistry)additive manufacturingPharmaceutics
researchProduct

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

2017

International audience; PurposeTo provide an up-to-date account of drug prescription during pregnancy in France from 2011 to 2014 using the permanent sample of the French national computerized healthcare database and with a focus on recommended supplementations, fetotoxic drugs and teratogenic drugs.MethodsAll pregnancies identified by the International Classification of Diseases, 10th Revision codes list in the hospitalization database, lasting more than 9 weeks of amenorrhea and whose delivery occurred between 01/01/2011 and 12/31/2014, were included. Drugs delivered between the trimester before and until the end of the pregnancy were included. Drug exposure prevalence was calculated for …

DrugAdultPediatricsmedicine.medical_specialtypharmacoepidemiologyPrescription drugPrescription DrugsNational Health ProgramsEpidemiologymedia_common.quotation_subject[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics030226 pharmacology & pharmacy03 medical and health sciencesYoung Adult0302 clinical medicinePregnancymedicineHumansPharmacology (medical)Medical prescriptionPregnancy Trimestersmedia_commonPregnancy030219 obstetrics & reproductive medicinebusiness.industrydrug recommendationsadministrative healthcare databasePharmacoepidemiologymedicine.diseaseDrug classTeratogensprescription medicationsAmenorrheaFemaleFrancePregnancy Trimestersmedicine.symptombusinessPharmacoepidemiology and drug safety
researchProduct

Long-Circulating Hyaluronan-Based Nanohydrogels as Carriers of Hydrophobic Drugs

2018

[EN] Nanohydrogels based on natural polymers, such as polysaccharides, are gaining interest as vehicles for therapeutic agents, as they can modify the pharmacokinetics and pharmacodynamics of the carried drugs. In this work, hyaluronan-riboflavin nanohydrogels were tested in vivo in healthy rats highlighting their lack of toxicity, even at high doses, and their different biodistribution with respect to that of native hyaluronan. They were also exploited as carriers of a hydrophobic model drug, the anti-inflammatory piroxicam, that was physically embedded within the nanohydrogels by an autoclave treatment. The nanoformulation was tested by intravenous administration showing an improvement of…

DrugBiodistributionmedia_common.quotation_subjectRiboflavinPharmaceutical Sciencelcsh:RS1-441Pharmacokinetic02 engineering and technologyPharmacologyPiroxicam030226 pharmacology & pharmacyArticleNanohydrogelsLong circulatinglcsh:Pharmacy and materia medica03 medical and health sciencesPiroxicam0302 clinical medicineBiodistributionPharmacokineticsIn vivomedicineHyaluronanbiodistribution; hyaluronan; hydrophobic drugs; nanohydrogels; pharmacokinetic; piroxicam; riboflavinmedia_commonChemistry021001 nanoscience & nanotechnologyHydrophobic drugsToxicityCirculation time0210 nano-technologymedicine.drug
researchProduct